Ingrid Hoos

Consejero General en ETON PHARMACEUTICALS, INC. .

Health Technology

Consumer Services

Perfil

Ingrid Hoos is currently working as the Senior Vice President of Regulatory Affairs at Eton Pharmaceuticals, Inc. She previously held the position of VP of Regulatory Affairs & Regulatory Compliance at Horizon Pharma, Inc. and worked in Regulatory Affairs at Baxter Healthcare, Inc. In terms of education, Ms. Hoos completed her undergraduate degree at Northeastern Illinois University.

Cargos activos de Ingrid Hoos

Empresas	Cargo	Inicio
ETON PHARMACEUTICALS, INC.	Consejero General	-

Todos los cargos activos de Ingrid Hoos

Antiguos cargos conocidos de Ingrid Hoos.

Empresas	Cargo	Fin
Baxter Healthcare, Inc.	Corporate Officer/Principal	-
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	Consejero General	-

Ver el detalle de la experiencia de Ingrid Hoos.

Formación de Ingrid Hoos.

Northeastern Illinois University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Ingrid Hoos.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ETON PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	2
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	Health Technology
Baxter Healthcare, Inc.